Clinical Trial Update: Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial) [Phase 2]

View source ↗

Summary

SWOG's expanded Lung-MAP trial is evaluating a targeted therapy for advanced non-small cell lung cancer with MET exon 14 skipping mutations; the Phase 2 study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 2 | Status: RECRUITING